Disseminated carcinoma diagnosed by bone marrow biopsy in patients with microangiopathic hemolytic anemia and thrombocytopenia: a report of two cases with gastric cancer and a review of the literature.
BACKGROUND
Malignancy is often associated with hematological disorders, but rarely is the diagnosis of malignancy secondary to the diagnosis of microangiopathic hemolytic anemia and thrombocytopenia.


METHODS
We report hereby two patients with metastatic gastric carcinoma presenting with microangiopathic hemolytic anemia and thrombocytopenia. Despite chemotherapy and repeated plasmapheresis in one patient, both patients succumbed shortly after the diagnosis of cancer was made.


CONCLUSIONS
A review of the literature regarding microangiopathic hemolytic anemia in cancer patients is discussed. In patients suffering from microangiopathic hemolytic anemia and thrombocytopenia, malignancy should be considered as a possible cause. Early diagnosis of malignancy may be critical for determining the patient's prognosis and potentially avoiding unnecessary overtreatment.
Kaidar-Person
Orit
O
Division of Oncology, Rambam Health Care Campus and Faculty of Medicine, Technion-Israel Institute of Technology, POB 9602, Haifa 31096, Israel.
Nasrallah
Haitam
H
Haim
Nissim
N
Dann
Eldad J
EJ
Bar-Sela
Gil
G
D000230:Adenocarcinoma / Q000175:diagnosis*; D000328:Adult; D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011697:Purpura, Thrombotic Thrombocytopenic / Q000175:diagnosis* / Q000628:therapy; D013274:Stomach Neoplasms / Q000175:diagnosis*; D013921:Thrombocytopenia / Q000175:diagnosis* / Q000628:therapy
N Engl J Med. 2006 May 4;354(18):1927-35
16672704
Crit Rev Oncol Hematol. 1991 Dec;11(4):243-65
1777089
Ann Oncol. 2008 Jun;19(6):1204-7
18407952
J Hematol Oncol. 2008 Dec 01;1:23
19046460
Semin Hematol. 1987 Jul;24(3):161-77
3310241
Arch Pathol Lab Med. 2003 Jul;127(7):834-9
12823037
N Engl J Med. 1991 Aug 8;325(6):393-7
2062330
Blood. 1984 Sep;64(3):592-8
6432074
N Engl J Med. 1998 Nov 26;339(22):1578-84
9828245
J Clin Oncol. 1989 Jun;7(6):781-9
2497229
Am J Med. 1999 Dec;107(6):573-9
10625026
Semin Thromb Hemost. 2005 Dec;31(6):681-90
16388419
Blood. 1998 Apr 15;91(8):2839-46
9531594
Haematologica. 2002 Jan;87(1):ECR01
11801475
Blood. 2010 Feb 25;115(8):1500-11; quiz 1662
20032506
Lancet Oncol. 2007 Jul;8(7):634-41
17613425
N Engl J Med. 1998 Nov 26;339(22):1585-94
9828246
JAMA. 1985 Nov 8;254(18):2554-5
4057460
N Engl J Med. 1991 Aug 8;325(6):398-403
2062331
New Istanbul Contrib Clin Sci. 1975 Jun;11(2):103-7
174059
Oncologist. 2005 Apr;10(4):299-300
15821250
Clin Nephrol. 1987 Jan;27(1):46
3815908
Cancer. 1995 Mar 1;75(5):1167-70
7850716
Blood. 2000 Aug 15;96(4):1223-9
10942361
Nature. 2001 Oct 4;413(6855):488-94
11586351
Semin Hematol. 1997 Apr;34(2):159-66
9109218
Oncologist. 2007 Jan;12(1):11-9
17227897
Hematopathol Mol Hematol. 1996;10(3):161-70
8878734
Ther Apher Dial. 2010 Apr;14(2):222-5
20438546